Officer/Director Hui Wang Files Intent to Sell $3.4M in Shares, Adding to Recent $10.5M Sales
ACMR has more than doubled off its 52-week low of $22.875.
Summary
An Officer and Director of ACM Research, Hui Wang, plans to sell $3.4 million in shares, continuing a trend of significant insider selling that totals nearly $14 million in the last three months.
Key Events · Ownership and Investor Activity · ACMR
-
Proposed Share Sale
Officer and Director Hui Wang filed a Form 144 to sell 40,002 common shares, valued at approximately $3.43 million.
-
Recent Insider Selling History
This proposed sale follows previous sales by Hui Wang totaling 170,000 shares for $10.56 million over the past three months.
-
Ongoing Insider Distribution
The combined sales by this key insider amount to nearly $14 million, contributing to a broader pattern of insider distribution noted in recent activity.
-
Context of High Stock Price
The intent to sell comes as the company's stock is trading near its 52-week high.
Analysis · ACMR · Technology
Hui Wang, an Officer and Director, has filed a Form 144 indicating an intent to sell an additional $3.4 million worth of shares. This follows approximately $10.5 million in sales by Wang over the past three months, contributing to a broader pattern of insider distribution. The ongoing selling by a key insider, especially while the stock is near its 52-week high and the company recently completed a dilutive capital raise, could be interpreted negatively by investors.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACMR was trading at $90.21 on NASDAQ in the Technology sector, with a market capitalization of approximately $6.2B. The 52-week trading range was $22.88 to $94.21. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.